Emerging neuroprotective effect of metformin in Parkinsons disease: a molecular crosstalk
Combining glucose metabolic regulation with programmed cell death Programmed cell death (PCD) is a tightly regulated process in multicellular organisms that eliminates superfluous or abnormal cells through various forms, including apoptosis, ferroptosis, cuproptosis, and pyroptosis
Wang R, Lagakos SW, Ware JH, et al
it is embedded in a network of opposing and cooperating factors
However, results from prior phase 2 studies in treatment-experienced GT3-infected patients without cirrhosis treated for 12 weeks demonstrated a similar tendency toward lower efficacy, with an SVR12 rate of 89% (24/27) with two relapses.[21] Notably, the 16-week regimen of G/P is now approved by the US Food and Drug Administration and the European Medicines Agency for the treatment of GT3-infected patients with prior treatment experience (with or without cirrhosis), supported by data from prior phase 2 studies and this phase 3 study, demonstrating an overall 96% (66/69) SVR12 rate in this subpopulation.[20] Among patients with baseline NS5A polymorphisms and compensated cirrhosis (n = 15, including 5 with Y93H at baseline), all achieved SVR12
